Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Clozel.png?h=395&iar=0&w=600&hash=8D855577E794E4AF859DA0F3582AB75F
Jean-Paul Clozel
Actelion in $360M settlement - San Francisco Business Times
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann
Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
Idorsia 'cuts Actelion umbilical cord', says cash pile suffices
Ein schweres Erbe für Jean-Paul Clozel | NZZ
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Jean-Paul Clozel
Jean-Paul Clozel
Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds | Reuters
Jean-Paul Clozel – mit Herzblut für Actelion - Rendez-vous - SRF
Jean-Paul Clozel
Börsengang zahlt sich für Ehepaar Clozel aus | FM1Today
Idorsia Pharmaceuticals Ltd - Our CEO, Jean-Paul Clozel closed out the year with the remark: We advanced each of our clinical programs, with the first Phase 3 results expected soon. Since the
Idorsia, a small company with a big portfolio says Martine Clozel
Jean-Paul Clozel
Profile: Jean-Paul Clozel | Nature Biotechnology
World Entrepreneur 2008Dr Jean -Paul Clozel with wife Mart… | Flickr
Idorsia: Failure in Phase III - European Biotechnology
History
